Literature DB >> 27408116

Contraceptive Effectiveness of Levonorgestrel Releasing Intrauterine System.

A Kapur1, S Kumar2.   

Abstract

BACKGROUND: This study evaluated the contraceptive effectiveness of progesterone releasing intrauterine contraceptive devices (IUCD) and compared it with the Copper T device.
METHODS: Seventy patients were selected in each group. Menstrual charts were maintained and data recorded at one, three, six months and one year after insertion of the device. RESULT: One year follow up was completed by 66 patients in the Levonorgestrel Releasing Intrauterine System (LNG-IUS) group and 62 in the Cu T group. They were age, parity and education level matched. The mean duration of menstrual flow for the LNG-IUS group was 3.6 days and that for CuT group was 5.1 days (p>0.05). Insertion of LNG-IUS was found to be significantly difficult than the Cu T 380, with increased pain at insertion (p<0.05). There was no pregnancy in the LNG-IUS group and expulsion rates were low. The most significant difference was scanty periods and at times amenorrhoea in the LNG-IUS group. Termination rates for various reasons were almost equal in both groups.
CONCLUSION: Both devices were effective, safe, well accepted and tolerated. LNG-IUS scores high in patients with preexisting menorrhagia or dysmenorrhoea while Cu T 380 has advantages of lower cost, ease of insertion and comparable efficacy.

Entities:  

Keywords:  Amenorrhea; Contraception; Copper T 380; Levonorgestrel intrauterine system; Menorrhagia

Year:  2011        PMID: 27408116      PMCID: PMC4921528          DOI: 10.1016/S0377-1237(08)80058-5

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  4 in total

1.  A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.

Authors:  Ayman H Shaamash; Gamal H Sayed; Mostafa M Hussien; Mamdouh M Shaaban
Journal:  Contraception       Date:  2005-07-06       Impact factor: 3.375

2.  [Acceptability of intrauterine levonorgestrel delivery system (Mirena 52mg) after estrogen-progesterone oral contraception: results of a prospective multicentric study of 211 patients aged 25-35 years].

Authors:  P Collinet; M Nayama; M Cosson
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2006-12

3.  Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR).

Authors:  I Sivin; J Stern
Journal:  Fertil Steril       Date:  1994-01       Impact factor: 7.329

Review 4.  Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.

Authors:  T Luukkainen; J Toivonen
Journal:  Contraception       Date:  1995-11       Impact factor: 3.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.